aminopropionitrile has been researched along with Abdominal Aortic Aneurysm in 19 studies
Aminopropionitrile: Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin II (AngII)-activated epidermal growth factor receptor has been implicated in abdominal aortic aneurysm (AAA) development." | 7.85 | Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm. ( Boyer, MJ; Cooper, HA; Eguchi, S; Forrester, SJ; Hashimoto, T; Kawai, T; Kobayashi, T; Kwok, HF; Obama, T; Preston, KJ; Rizzo, V; Scalia, R; Takayanagi, T; Tsuji, T, 2017) |
| "Angiotensin II (AngII) is a potential contributor to the development of abdominal aortic aneurysm (AAA)." | 4.02 | Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm. ( Choi, ET; Cicalese, S; Cooper, HA; Eguchi, S; Kasahara, S; Kawai, T; Okuno, K; Otaka, N; Preston, KJ; Rizzo, V; Scalia, R; Uchida, HA, 2021) |
| "Angiotensin II (AngII)-activated epidermal growth factor receptor has been implicated in abdominal aortic aneurysm (AAA) development." | 3.85 | Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm. ( Boyer, MJ; Cooper, HA; Eguchi, S; Forrester, SJ; Hashimoto, T; Kawai, T; Kobayashi, T; Kwok, HF; Obama, T; Preston, KJ; Rizzo, V; Scalia, R; Takayanagi, T; Tsuji, T, 2017) |
| "Angiotensin II (Ang II) has been implicated in the development of abdominal aortic aneurysm (AAA)." | 3.81 | Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model. ( Choi, E; Daugherty, A; Eguchi, S; Elliott, KJ; Forrester, SJ; Fukuda, Y; Kawai, T; Kobayashi, T; Obama, T; Rizzo, V; Takayanagi, T; Taro, Y; Tsuji, T, 2015) |
| "Large animal models to study abdominal aortic aneurysms are sparse." | 1.51 | Porcine Model of Infrarenal Abdominal Aortic Aneurysm. ( Ailawadi, G; Cullen, JM; Dahl, JJ; Johnston, WF; Lu, G; Montgomery, WG; Salmon, M; Scott, EJ; Shannon, AH; Spinosa, MD; Tyerman, Z; Upchurch, GR, 2019) |
| "β-Aminopropionitrile (BAPN) is a compound known to cause aortic aneurysms by inhibiting lysyl oxidase, a collagen cross-linking enzyme." | 1.51 | A novel swine model of abdominal aortic aneurysm. ( Ailawadi, G; Cullen, JM; Fashandi, AZ; Johnston, WF; Lu, G; Montgomery, WG; Salmon, M; Shannon, AH; Sharma, A; Spinosa, MD; Su, G; Upchurch, GR, 2019) |
| "Azelnidipine treatment reduced the pathologic findings normally associated with aneurysm formation within the aortic wall." | 1.39 | Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects. ( Hirata, Y; Kitagawa, T; Kurobe, H; Matsuoka, Y; Maxfield, MW; Sata, M; Sugasawa, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 7 (36.84) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, YC | 1 |
| Zhang, XJ | 1 |
| Zhang, JX | 1 |
| Zhai, ZY | 1 |
| Zhang, MX | 1 |
| Jiang, BH | 1 |
| Berman, AG | 3 |
| Romary, DJ | 2 |
| Kerr, KE | 1 |
| Gorazd, NE | 1 |
| Wigand, MM | 1 |
| Patnaik, SS | 1 |
| Finol, EA | 1 |
| Cox, AD | 1 |
| Goergen, CJ | 3 |
| Okuno, K | 2 |
| Torimoto, K | 1 |
| Cicalese, SM | 1 |
| Hashimoto, T | 3 |
| Sparks, MA | 1 |
| Rizzo, V | 4 |
| Eguchi, S | 4 |
| Fashandi, AZ | 2 |
| Spinosa, M | 1 |
| Salmon, M | 3 |
| Su, G | 4 |
| Montgomery, W | 1 |
| Mast, A | 1 |
| Lu, G | 4 |
| Hawkins, RB | 1 |
| Cullen, JM | 3 |
| Sharma, AK | 2 |
| Ailawadi, G | 5 |
| Upchurch, GR | 5 |
| Shannon, AH | 2 |
| Dahl, JJ | 1 |
| Scott, EJ | 1 |
| Tyerman, Z | 1 |
| Spinosa, MD | 2 |
| Montgomery, WG | 2 |
| Johnston, WF | 2 |
| Lu, H | 1 |
| Sun, J | 1 |
| Liang, W | 1 |
| Chang, Z | 1 |
| Rom, O | 1 |
| Zhao, Y | 1 |
| Zhao, G | 1 |
| Xiong, W | 1 |
| Wang, H | 1 |
| Zhu, T | 1 |
| Guo, Y | 1 |
| Chang, L | 1 |
| Garcia-Barrio, MT | 1 |
| Zhang, J | 1 |
| Chen, YE | 1 |
| Fan, Y | 1 |
| Cooper, HA | 2 |
| Cicalese, S | 1 |
| Preston, KJ | 2 |
| Kawai, T | 3 |
| Choi, ET | 1 |
| Kasahara, S | 1 |
| Uchida, HA | 1 |
| Otaka, N | 1 |
| Scalia, R | 2 |
| Weiss, D | 2 |
| Latorre, M | 1 |
| Rego, BV | 1 |
| Cavinato, C | 1 |
| Tanski, BJ | 1 |
| Humphrey, JD | 1 |
| Takayanagi, T | 2 |
| Forrester, SJ | 2 |
| Obama, T | 2 |
| Tsuji, T | 2 |
| Kobayashi, T | 2 |
| Boyer, MJ | 1 |
| Kwok, HF | 1 |
| Sharma, A | 1 |
| Kurobe, H | 1 |
| Matsuoka, Y | 1 |
| Hirata, Y | 1 |
| Sugasawa, N | 1 |
| Maxfield, MW | 1 |
| Sata, M | 1 |
| Kitagawa, T | 1 |
| English, SJ | 1 |
| Piert, MR | 1 |
| Diaz, JA | 1 |
| Gordon, D | 1 |
| Ghosh, A | 1 |
| DʼAlecy, LG | 1 |
| Whitesall, SE | 1 |
| DeRoo, EP | 1 |
| Watt, T | 1 |
| Henke, PK | 1 |
| Eliason, JL | 1 |
| Fukuda, Y | 1 |
| Taro, Y | 1 |
| Elliott, KJ | 1 |
| Choi, E | 1 |
| Daugherty, A | 1 |
| Imanishi, M | 1 |
| Chiba, Y | 1 |
| Tomita, N | 1 |
| Matsunaga, S | 1 |
| Nakagawa, T | 1 |
| Ueno, M | 1 |
| Yamamoto, K | 1 |
| Tamaki, T | 1 |
| Tomita, S | 1 |
| Davis, JP | 1 |
| Schaheen, B | 1 |
| Downs, E | 1 |
| Roy, RJ | 1 |
| Kanematsu, Y | 1 |
| Kanematsu, M | 1 |
| Kurihara, C | 1 |
| Tsou, TL | 1 |
| Nuki, Y | 1 |
| Liang, EI | 1 |
| Makino, H | 1 |
| Remus, EW | 1 |
| O'Donnell, RE | 1 |
| Rafferty, K | 1 |
| Joseph, G | 1 |
| Csiszar, K | 1 |
| Fong, SF | 1 |
| Taylor, WR | 1 |
| Huffman, MD | 1 |
| Curci, JA | 1 |
| Moore, G | 1 |
| Kerns, DB | 1 |
| Starcher, BC | 1 |
| Thompson, RW | 1 |
19 other studies available for aminopropionitrile and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Progression and Regression of Abdominal Aortic Aneurysms in Mice.
Topics: Aminopropionitrile; Animals; Aortic Aneurysm, Abdominal; Collagen; Disease Models, Animal; Disease P | 2021 |
Experimental aortic aneurysm severity and growth depend on topical elastase concentration and lysyl oxidase inhibition.
Topics: Administration, Topical; Aminopropionitrile; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; | 2022 |
Smooth muscle angiotensin II type 1A receptor is required for abdominal aortic aneurysm formation induced by angiotensin II plus β-aminopropionitrile.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Hum | 2023 |
High-frequency murine ultrasound provides enhanced metrics of BAPN-induced AAA growth.
Topics: Aminopropionitrile; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Biomechanical Phenomena; | 2019 |
Female Mice Exhibit Abdominal Aortic Aneurysm Protection in an Established Rupture Model.
Topics: Administration, Oral; Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm | 2020 |
Porcine Model of Infrarenal Abdominal Aortic Aneurysm.
Topics: Aminopropionitrile; Angioplasty, Balloon; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Col | 2019 |
Cyclodextrin Prevents Abdominal Aortic Aneurysm via Activation of Vascular Smooth Muscle Cell Transcription Factor EB.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Aminopropionitrile; Aneurysm, Ruptured; Angiotensin II; Animals; | 2020 |
Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm.
Topics: Aminopropionitrile; Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneu | 2021 |
Biomechanical consequences of compromised elastic fiber integrity and matrix cross-linking on abdominal aortic aneurysmal enlargement.
Topics: Aminopropionitrile; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; E | 2021 |
Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.
Topics: ADAM17 Protein; Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdo | 2017 |
A novel swine model of abdominal aortic aneurysm.
Topics: Aminopropionitrile; Angioplasty, Balloon; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Col | 2019 |
Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
Topics: Aminopropionitrile; Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aorta, Thor | 2013 |
Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.
Topics: Aminopropionitrile; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Biomarker | 2015 |
Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Ru | 2015 |
Hypoxia-Inducible Factor-1α in Smooth Muscle Cells Protects Against Aortic Aneurysms-Brief Report.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abd | 2016 |
A novel chronic advanced stage abdominal aortic aneurysm murine model.
Topics: Aminopropionitrile; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Chronic D | 2017 |
Pharmacologically induced thoracic and abdominal aortic aneurysms in mice.
Topics: Aminopropionitrile; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Aortic Aneurysm, A | 2010 |
The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysms.
Topics: Amino Acid Oxidoreductases; Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic An | 2012 |
Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms.
Topics: Aminopropionitrile; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Connective Tissue; Desmos | 2000 |